Page 1836 - Hematology_ Basic Principles and Practice ( PDFDrive )

1632.e6 Part X Transplantation

195. Ringdén O, Labopin M, Ciceri F, et al: Is there a stronger graft- 200. Ghiso A, Raiola AM, Gualandi F, et al: DLI after haploidentical BMT
versus-leukemia effect using HLA-haploidentical donors than with with post-transplant CY. Bone Marrow Transplant 50:56, 2015.
HLA-identical siblings? Leukemia 30:447, 2016. 201. Zeidan AM, Forde PM, Symons H, et al: HLA-haploidentical donor
196. Shaw BE, Marsh SGE, Mayor NP, et al: HLA-DPB1 matching status lymphocyte infusions for patients with relapsed hematologic malignan-
has significant implications for recipients of unrelated donor stem cell cies after related HLA-haploidentical bone marrow transplantation. Biol
transplants. Blood 107(3):1220–1226, 2006. Blood Marrow Transplant 20(3):314–318, 2014.
197. Vago L, Perna SK, Zanussi M, et al: Loss of mismatched HLA in leu- 202. Yan CH, Liu DH, Xu LP, et al: Modified donor lymphocyte infusion-
kemia after stem-cell transplantation. N Engl J Med 361(5):478–488, associated acute graft-versus-host disease after haploidentical T-cell-
2009. replete hematopoietic stem cell transplantation: incidence and risk
198. Villalobos IB, Takahashi Y, Akatsuka Y, et al: Relapse of leukemia factors. Clin Transplant 26:868, 2012.
with loss of mismatched HLA resulting from uniparental disomy 203. Yan CH, Wang JZ, Liu DH, et al: Chemotherapy followed by modified
after haploidentical hematopoietic stem cell transplantation. Blood donor lymphocyte infusion as a treatment for relapsed acute leukemia
115(15):3158–3161, 2010. after haploidentical hematopoietic stem cell transplantation without
199. Crucitti L, Crocchiolo R, Toffalori C, et al: Incidence, risk factors and in vitro T-cell depletion: superior outcomes compared with chemo-
clinical outcome of leukemia relapses with loss of the mismatched HLA therapy alone and an analysis of prognostic factors. Eur J Haematol
after partially incompatible hematopoietic stem cell transplantation. 91(4):304–314, 2013.
Leukemia 29(5):1143–1152, 2015.